Serial #50148232
LIVE

Serial Number

50148232

Owner

Orchestra Life Sciences Co., LLC

Attorney

Julie C. Scheipeter

First Use Date

Jul 11, 2023

Filing Date

Oct 7, 2026

Add to watchlist:

No watchlists yet
View on USPTO

Serial #50148232 Trademark

Serial Number: 50148232

Serial #50148232 is a trademark filed by Orchestra Life Sciences Co., LLC on October 7, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Orchestra Life Sciences Co., LLC (2 trademarks)

120 S. Central Avenue Suite 1800
St. Louis, MO 63105

Entity Type: 16

Trademark Details

Filing Date

October 7, 2026

Registration Date

Not Registered

First Use Anywhere

July 11, 2023

First Use in Commerce

August 23, 2023

Goods & Services

regulatory compliance consulting in the fields of pharmaceuticals and biotechnology

business consulting and management services in the field of clinical trials, namely, providing information management, clinical data management, and regulatory submission management services on behalf of medical, biopharmaceutical, and biotechnology companies to assist with clinical research, clinical trials, and applications for drug approval; business consulting services relating to product distribution, operations management, logistics, reverse logistics, supply chain, and production and distribution systems; providing business intelligence services in the fields of medical devices, pharmaceuticals, and the life sciences; regulatory submission management services, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business strategy development services in the fields of pharmaceuticals and biotechnology.

technical and scientific consulting services in the fields of pharmaceutical studies, scientific research, and pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, genetics, and clinical trials; research and development services in the pharmaceutical, biotechnology, and life sciences fields; medical and scientific research in the field of cancer treatment and diagnosis; biotechnology research and consulting services; consulting services for others in the field of engineering, namely, design, development, and project management of capital projects, including planning and implementation of engineering processes

Filing History

APPLICATION FILING RECEIPT MAILED
Oct 7, 2026 MAFR
NEW APPLICATION ENTERED
Oct 7, 2026 NWAP